• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ImageneBio, Inc. - Common Stock (NQ:IMA)

    6.000 +0.310 (+5.45%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,301
    Open 5.640
    Bid (Size) 5.200 (100)
    Ask (Size) 6.330 (200)
    Prev. Close 5.690
    Today's Range 5.640 - 6.120
    52wk Range 3.940 - 8.950
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
    From ImageneBio, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -11.2%
    -11.2%
    1 Month
    +14.3%
    +14.3%
    3 Month
    +5.4%
    +5.4%
    6 Month
    -3.1%
    -3.1%
    1 Year
    -30.6%
    -30.6%

    More News

    Read More
    News headline image
    ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology
    Via AB Newswire
    News headline image
    ImageneBio Announces $30 Million Private Placement
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio to Participate in Leerink Global Healthcare Conference
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
    From ImageneBio, Inc.
    Via GlobeNewswire
    News headline image
    This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
    Via Benzinga

    Frequently Asked Questions

    Is ImageneBio, Inc. - Common Stock publicly traded?
    Yes, ImageneBio, Inc. - Common Stock is publicly traded.
    What exchange does ImageneBio, Inc. - Common Stock trade on?
    ImageneBio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ImageneBio, Inc. - Common Stock?
    The ticker symbol for ImageneBio, Inc. - Common Stock is IMA on the Nasdaq Stock Market
    What is the current price of ImageneBio, Inc. - Common Stock?
    The current price of ImageneBio, Inc. - Common Stock is 6.000
    When was ImageneBio, Inc. - Common Stock last traded?
    The last trade of ImageneBio, Inc. - Common Stock was at 06/18/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.